Results

Total Results: 2,217 records

Showing results for "disease".

181. Archived: Dementia in Older Adults: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/dementia-older-adults-screening-2003
     June 03, 2003 - Mild cognitive impairment represents early-stage Alzheimer disease. … The US economic and social costs of Alzheimer's disease revisited. … Early identification of Alzheimer's disease and related dementias . … Rivastigmine for Alzheimer's disease (Cochrane Review). … Selegiline for Alzheimer's disease (Cochrane Review).

182. Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/gXnmnkofo8FxoLnCmXJDjb
     October 01, 2009 - Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. … Periodontal Disease Fair-quality evidence indicates that periodontal disease can predict CHD risk independent … Of note, these studies did not consistently define periodontal disease or CHD outcomes. … coronary heart disease incidence: a systematic review and meta- analysis. … Homocysteine low- ering with folic acid and B vitamins in vascular disease.

183. Screening for Coronary Heart Disease With Electrocardiography: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/awaTJS5m8ZC5vUTKHZfMwD
     July 23, 2012 - Screening for Coronary Heart Disease With Electrocardiography: Clinical Summary of USPSTF Recommendation … SCREENING FOR CORONARY HEART DISEASE WITH ELECTROCARDIOGRAPHY CLINICAL SUMMARY OF U.S. … SERVICES TASK FORCE RECOMMENDATION Population Asymptomatic adults at low risk for coronary heart disease … on screening for carotid artery stenosis, high blood pressure, lipid disorders, peripheral arterial disease

184. Clinical Summary: Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/uPbfDukSXmFDWq8FDwTgKj
     July 03, 2018 - Clinical Summary: Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors … Clinical Summary: Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors Population … A value <0.9 indicates peripheral artery disease. hsCRP is a serum protein involved in inflammatory … smoking cessation, counseling on healthful diet and physical activity, screening for peripheral artery disease

185. Final Recommendation Statement: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/statin-use-in-adults-preventive-medication
     August 23, 2022 - Final Recommendation Statement Statin Use for the Primary Prevention of Cardiovascular Disease … diseases, HIV, and South Asian ancestry. 42 , 43 The 2014 US Department of Veterans Affairs/US Department … Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. … Cholesterol lowering in intermediate-risk persons without cardiovascular disease. … Abbreviations: CVD, cardiovascular disease; USPSTF, US Preventive Services Task Force.

186. Archived: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
     March 14, 2014 - years is required to prevent one coronary heart disease event. … Washington, DC: Office of Disease Prevention and Health Promotion, U.S. … Prediction of coronary heart disease using risk factor categories. … Updated New Zealand cardiovascular disease risk-benefit prediction guide.  … Lowering the blood total cholesterol level to prevent coronary heart disease.

187. Procedure Manual Appendix V. Work Plan/Research Plan Template | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/procedure-manual/procedure-manual-appendix-v-work-planresearch-plan-template
     July 01, 2017 - What defines the disease/condition of interest? Prevalence and burden of disease/illness. … Who is primarily affected by this disease/condition? … What causes the disease/condition? … How is the disease/condition detected? … Diseases.

188. Procedure Manual Appendix V. Work Plan/Research Plan Template | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-v-work-planresearch-plan-template
     July 01, 2017 - What defines the disease/condition of interest? Prevalence and burden of disease/illness. … Who is primarily affected by this disease/condition? … What causes the disease/condition? … How is the disease/condition detected? … Diseases.

189. Public Comment on Draft Recommendation: Screening for Chronic Kidney Disease | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-screening-chronic-kidney-disease
     May 29, 2012 - Public Comment on Draft Recommendation: Screening for Chronic Kidney Disease Share to Facebook … Services Task Force released today its draft recommendation statement on Screening for Chronic Kidney Disease … recommendation statement and the evidence that it is based on, go to: /uspstf/recommendation/chronic-kidney-disease-ckd-screening

190. Final Recommendation Statement: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-statin-use-primary-prevention-cardiovascular-disease-adults
     November 13, 2016 - Final Recommendation Statement: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults … released today a final recommendation statement on statin use for the primary prevention of cardiovascular disease … use is beneficial for some people ages 40 to 75 years who are at increased risk for cardiovascular disease

191. Public Comment on Key Questions of the Evidence: Screening for Chronic Kidney Disease in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-key-questions-evidence-screening-chronic-kidney-disease-adults
     March 01, 2010 - Public Comment on Key Questions of the Evidence: Screening for Chronic Kidney Disease in Adults … opportunity for public comment on the key questions of the evidence on Screening for Chronic Kidney Disease … and select "Comparative Effectiveness Screening, Monitoring, and Treatment of Early Chronic Kidney Disease

192. Final Evidence Review: Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/peripheral-artery-disease-in-adults-screening-with-the-ankle-brachial-index
     July 10, 2018 - Share to Email Print Final Evidence Review Peripheral Artery Disease … and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index July … Recommendation Expand All Panel 1 Screening for Peripheral Artery Disease

193. Archived: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-february-2014
     February 15, 2014 - stress may play a fundamental role in the initiation and progression of cancer and common cardiovascular diseases … Cardiovascular disease and cancer are the largest contributors to the burden of chronic disease in … In 2011, these diseases accounted for 23.7% and 22.8% of all deaths in the United States, respectively … Two trials assessed cardiovascular disease outcomes. … None of the studies reported cardiovascular disease incidence.

194. PII: S0749-3797(01)00266-5 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/aJ-xmGLsKqLQbQsBqodKZ5
     January 01, 2001 - for lipid disorders and treat abnor- mal lipids in people who are at increased risk of coronary heart disease … lipid measurement can identify asymptomatic middle-aged people at increased risk of coronary heart disease … years is required to prevent one coronary heart disease event. … Washington, DC: Office of Disease Prevention and Health Promo- tion, U.S. … Lowering the blood total cholesterol level to present coronary heart disease.

195. Final Recommendation Statement: Screening for Cardiovascular Disease Risk With Electrocardiography | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-screening-cardiovascular-disease-risk-electrocardiography
     June 12, 2018 - Final Recommendation Statement: Screening for Cardiovascular Disease Risk With Electrocardiography … Services Task Force released today a final recommendation statement on screening for cardiovascular disease

196. Public Comment on Draft Research Plan: Screening for Celiac Disease | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-screening-celiac-disease
     August 27, 2014 - Public Comment on Draft Research Plan: Screening for Celiac Disease Share to Facebook … Preventive Services Task Force posted today a draft research plan on screening for celiac disease.

197. Clinical Summary: Screening for Cardiovascular Disease Risk With Electrocardiography (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/tHHBn5j3PD_Bnjk7q6tACS
     June 05, 2018 - Clinical Summary: Screening for Cardiovascular Disease Risk With Electrocardiography Clinical … Summary: Screening for Cardiovascular Disease Risk With Electrocardiography Population Adults at low

198. U.S. Preventive Services Task Force Issues Draft Recommendation Statement on Statin Use for the Primary Prevention of Cardiovascular Disease in Adults (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/statinscvdadultsdraftrsbulletin.pdf
     December 22, 2015 - Force Issues Draft Recommendation Statement on Statin Use for the Primary Prevention of Cardiovascular Disease … Issues Draft Recommendation Statement on Statin Use for the Primary Prevention of Cardiovascular Disease … that statin use is beneficial for some people aged 40 to 75 at increased risk for cardiovascular disease … to assess the balance of the benefits and harms of statin use for the prevention of cardiovascular disease … “People with no signs, symptoms, or history of cardiovascular disease can still be at risk for having

199. Final Research Plan: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening
     September 25, 2014 - risk for progression from LTBI to active TB disease) improves quality of life, reduces active TB disease … incidence, reduces transmission of TB, or reduces disease-specific or overall mortality? … regimens improve quality of life or reduce progression to active TB disease, reduce transmission of … TB, or reduce disease-specific or overall mortality? … is part of standard disease management.

200. Archived: Final Research Plan: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening-september-2016
     September 25, 2014 - risk for progression from LTBI to active TB disease) improves quality of life, reduces active TB disease … incidence, reduces transmission of TB, or reduces disease-specific or overall mortality? … regimens improve quality of life or reduce progression to active TB disease, reduce transmission of … TB, or reduce disease-specific or overall mortality? … is part of standard disease management.